New York, NY, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Metastatic Bone Disease Market – by Treatment (Medication, Radiation Therapy, Surgical Intervention, and Tumor Ablation Therapy), by Origin (Breast, Lung, Thyroid, Kidney, Prostate & Others), and by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024” . According to the report, global  metastatic bone disease market  was valued at approximately USD 12295.6 million in 2017 and is expected to generate revenue of around USD 20,992.7 million by end of 2024, growing at a CAGR of around 7.89% between 2018 and 2024. 

The metastatic bone disease is a condition that arises from cancer spread to the bones at an advanced stage. This condition causes bone degeneration, fractures, severe pain, anemia, and others. This will increase the cost of treatment, duration, and has very fewer chances of cure and survival. The disease can be diagnosed with the help of CT scan and treatment includes the treatment and control of fractures, pain management, and local tumor control. Treatment options used for the treatment are completely based on the patient condition, response, and the status of the disease. The metastatic bone disease is caused due to the widespread of cancer from other parts to the bone this will lead to the weakening and degeneration of bones. 

Browse through 71 Tables & 15 Figures spread over 110 Pages and in-depth TOC on “Global Metastatic Bone Disease Market: By Type, Size, Industry Share, Trends, Growth Analysis and Forecast, 2017- 2024”.

Request Free Sample Report of Global Metastatic Bone Disease Market Report @ https://www.zionmarketresearch.com/sample/met...ase-market

Metastatic bone disease market is mainly driven by the increased prevalence of cancer over a period of time and an increase in the awareness among people. As per National Cancer Institute report, every year 439.2 per 100,000 men and women are diagnosed with some type of cancer and it is estimated that in 2018, 1,735,350 new cases of cancer will be diagnosed in the United States. Furthermore, increase in the research and development by the various pharmaceutical companies and FDA approval for various drugs led to the drug launch which is expected to fuel the growth metastatic bone disease market. Moreover, various reimbursement policies and strict regulations will allow better quality product and various initiatives by government and organization to create awareness; this will support the growth of metastatic bone disease market over the forecast period.

Metastatic bone disease market is segmented on the basis of treatment, the origin of metastasis, and end user. On the basis of treatment, the market is segmented into medication, radiation therapy, surgical intervention, and tumor ablation therapy. Medication therapy will dominate the metastatic bone disease market. On the basis of the origin of metastasis, the market is segmented into breast, lung, thyroid, kidney, and prostate & others. Breast cancer is expected to dominate the market. On the basis of the end user, the market is segmented into hospitals, specialty clinic, and ambulatory surgical centers. Hospital segment is expected to dominate the market over the forecast period.

Download Free Report Brochure: https://www.zionmarketresearch.com/requestbro...ase-market

North America represents the developed market for metastatic bone disease market over the forecast period. The developed regions are expected to support the growth of the North America market. Due to the increased prevalence of cancer and increased investment in research, and developed which is further supported by the FDA approval and launch of various new drugs are expected to support the growth of the North America market. The U.S. is expected to grow with the highest CAGR over the forecast period closely followed by other countries of the region. Furthermore, reimbursement policies are very high in this region, which will further fuel the growth of metastatic bone disease market in the near future.

Europe is the second largest growing region of the metastatic bone disease market and is expected to grow significantly over the forecast period due to the technological advancement and increased prevalence of cancer, which is further supported by the research and development on drug development will fuel the growth of metastatic bone disease market over the forecast period.

Browse the full  "Metastatic Bone Disease Market – by Treatment (Medication, Radiation Therapy, Surgical Intervention, and Tumor Ablation Therapy), by Origin (Breast, Lung, Thyroid, Kidney, Prostate & Others), and by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024"  report at  https://www.zionmarketresearch.com/report/met...ase-market

The Asia Pacific is the fastest growing region over the forecast period and is expected to grow significantly. Increased awareness among people, increased prevalence of cancer, and FDA approval are expected to support the growth of metastatic bone disease market. Furthermore, increased awareness about personalized medicine for the treatment of such condition is expected to create opportunities for the metastatic bone disease market.

The Middle East and Africa are expected to grow moderately over the forecast period due to the various government initiatives for creating awareness among people. Latin America is expected to experience a considerable growth over the forecast period.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/me...ase-market

Some of the key players in metastatic bone disease market include Merck & Co., Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Amgen, Inc., Novartis AG, Bayer AG, BTG Plc, Fresenius Kabi AG, Medtronic, Boston Scientific Corporation, and others.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/3243

The report segments the global metastatic bone disease market as follows: 

Global Metastatic Bone Disease Market: Treatment Analysis

  • Medication
  • Radiation Therapy
  • Surgical Intervention
  • Tumor Ablation Therapy

Global Metastatic Bone Disease Market: Origin Analysis

  • Breast
  • Lung
  • Thyroid
  • Kidney
  • Prostate 
  • Others

Global Metastatic Bone Disease Market: End User Analysis

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

Global Metastatic Bone Disease Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research Follow Us Twitter: https://twitter.com/zion_research

Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com

Contact Us:

Joel John 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com